Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 841 to 855 of 1422 results for social care

  1. Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer (TA654)

    Evidence-based recommendations on osimertinib (Tagrisso) for untreated locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in adults.

    Technology appraisal guidance
    Published
    14 October 2020

    Sections for TA654

  2. Committee B members

    Find out more about the NICE technology appraisal advisory committee B members and their registered interests

  3. Gilteritinib for treating relapsed or refractory acute myeloid leukaemia (TA642)

    Evidence-based recommendations on gilteritinib (Xospata) for relapsed or refractory FLT3-mutation-positive acute myeloid leukaemia in adults.

    Technology appraisal guidance
    Published
    12 August 2020
    View recommendations

    Sections for TA642

  4. Organisation of care:- What is the clinical and cost effectiveness of alternative approaches to organising primary care compared with usual care for people with multimorbidity?

    Organisation of care:- What is the clinical and cost effectiveness of alternative approaches to organising primary care...

    Research recommendation
    Published
    18 October 2016

  5. Is a medication review more clinically and cost effective at reducing the suboptimal use of medicines and improving patient-reported outcomes, compared with usual care or other intervention in the UK setting?

    of medicines and improving patient-reported outcomes, compared with usual care or other intervention in the UK setting? Any explanatory...

    Research recommendation
    Published
    9 June 2015

  6. Barriers and facilitators:- What are the barriers and facilitators for young people and adults with coexisting severe mental illness and substance misuse to obtain an optimal service (including optimal time frame for delivering interventions) to meet their needs and enable their recovery?

    point in the care pathway the views and experiences expressed relate to. As such, it is difficult to fully break down the experience of...

    Research recommendation
    Published
    10 February 2017

  7. Is a medication review more clinically and cost effective at reducing the suboptimal use of medicines and medicines-related patient safety incidents, compared with usual care or other interventions, in children?

    medicines and medicines-related patient safety incidents, compared with usual care or other interventions, in children? Any explanatory...

    Research recommendation
    Published
    9 June 2015

  8. Short break services: What components of short break services are most effective for disabled children and young people with severe complex needs and their families and carers?

    research, see the rationale section on coordinating education, health and care (EHC) plan process changes with local services, training...

    Research recommendation
    Published
    8 April 2022

  9. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (TA151)

    Evidence-based recommendations on continuous subcutaneous insulin infusion (insulin pump therapy) for treating type 1 diabetes in adults and children.

    Technology appraisal guidance
    Published
    23 July 2008
    View recommendations

    Sections for TA151

  10. Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)

    Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection

    Evidence summary
    Published
    17 March 2015

  11. Mollii suit for spasticity (MIB100)

    NICE has a developed medtech innovation briefing on Mollii suit for spasticity .

    Medtech innovation briefing
    Published
    28 March 2017

  12. Holoclar for treating limbal stem cell deficiency after eye burns (TA467)

    Evidence-based recommendations on Holoclar (a layer of cells grown from cells taken from your own eye) for treating limbal stem cell deficiency in adults with eye burns.

    Technology appraisal guidance
    Published
    16 August 2017
    View recommendations

    Sections for TA467

  13. Physical activity: for NHS staff, patients and carers (QS84)

    This quality standard covers encouraging physical activity in people of all ages who are in contact with the NHS, including staff, patients and carers. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    25 March 2015
    View quality statements

    Sections for QS84

  14. What works? In the UK, how effective and cost effective are service delivery interventions such as peer support, contingency management or text messaging delivered alone or in combination (in conjunction with standard care) compared with standard care alone for young people and adults with coexisting severe mental illness and substance misuse?

    delivered alone or in combination (in conjunction with standard care) compared with standard care alone for young people...

    Research recommendation
    Published
    10 February 2017

  15. Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea (TA777)

    Evidence-based recommendations on solriamfetol (Sunosi) for treating excessive daytime sleepiness caused by obstructive sleep apnoea in adults.

    Technology appraisal guidance
    Published
    9 March 2022
    View recommendations

    Sections for TA777